In Part 2, we build on the foundations from our first series with a series of real-world hypotheticals that highlight why and how developers can create a market access strategy early in clinical development.

This conversation explores strategies around clinical trial design, anticipating investor questions, and strengthening competitive positioning, all critical elements for shaping long-term success.